Spanish biotechnology-dedicated venture capital firm Ysios Capital has raised €155m for its third fund, Ysios BioFund III, which has a final target of €200m.
Spanish biotechnology-dedicated venture capital firm Ysios Capital has raised €155m for its third fund, Ysios BioFund III, which has a final target of €200m.